Literature DB >> 9377555

p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene.

F Agani1, D G Kirsch, S L Friedman, M B Kastan, G L Semenza.   

Abstract

Hypoxia-induced neovascularization mediated by vascular endothelial growth factor (VEGF) contributes to tumor progression. Based on its effects when overexpressed in transient transfection assays, p53 has been proposed to repress VEGF transcription. To investigate this hypothesis, we have analyzed endogenous VEGF mRNA levels in Hep3B cells stably expressing an inducible p53-estrogen receptor fusion protein and in irradiated RKO cells expressing endogenous wild-type p53. In both cell lines, VEGF mRNA levels increased in response to hypoxia, either in the presence or absence of functional p53. Our data provide no evidence for a causal relationship between the loss of p53 activity and increased VEGF expression that is observed during tumor progression. Studies that attribute repressor functions to p53 based on analysis of cells transiently overexpressing this protein should be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9377555

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.

Authors:  Qi Niu; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lian-Hai Zhang
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Otto Warburg's contributions to current concepts of cancer metabolism.

Authors:  Willem H Koppenol; Patricia L Bounds; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2011-04-14       Impact factor: 60.716

3.  VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells.

Authors:  T Fujisawa; J Watanabe; Y Kamata; M Hamano; H Hata; H Kuramoto
Journal:  Hum Cell       Date:  2003-03       Impact factor: 4.174

Review 4.  Response of tumour cells to hypoxia: role of p53 and NFkB.

Authors:  J A Royds; S K Dower; E E Qwarnstrom; C E Lewis
Journal:  Mol Pathol       Date:  1998-04

5.  p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway.

Authors:  M Farhang Ghahremani; S Goossens; D Nittner; X Bisteau; S Bartunkova; A Zwolinska; P Hulpiau; K Haigh; L Haenebalcke; B Drogat; A Jochemsen; P P Roger; J-C Marine; J J Haigh
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

6.  DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.

Authors:  Milota Kaluzová; Stefan Kaluz; Michael I Lerman; Eric J Stanbridge
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells.

Authors:  Samarendra N Banerjee; Krishanu Sengupta; Snigdha Banerjee; Neela K Saxena; Sushanta K Banerjee
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

8.  Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53.

Authors:  S Ambs; W P Bennett; W G Merriam; M O Ogunfusika; S M Oser; M A Khan; R T Jones; C C Harris
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.